Published in Clin Immunol Immunopathol on July 01, 1976
Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med (1987) 1.58
Lymphocyte transformation in contact sensitivity. Immunology (1970) 1.54
The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells. Oncogene (2007) 1.41
Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results. Am J Obstet Gynecol (1995) 1.39
Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities. Obstet Gynecol (1990) 1.39
Sensitive chemiluminescent enzyme-linked immunosorbent assay for quantification of human immunoglobulin G and detection of herpes simplex virus. J Clin Microbiol (1981) 1.31
Immunocytochemical localization of the immunoglobulin factors Gm(a), Gm(b) and Inv(a) in human lymphoid tissue. Immunology (1966) 1.25
Indirect fluorescent-antibody test for human cytomegalovirus infection in the absence of interfering immunoglobulin G receptors. Infect Immun (1977) 1.18
Induction of delayed hypersensitivity by dinitrophenylated lymphocytes. Immunology (1970) 1.17
Microalbuminuria and hypertension in long-term renal donors. Transplantation (1988) 1.13
Coprecipitation of some cryomacroglobulins with immunoglobulins and their fragments. Arch Biochem Biophys (1965) 1.10
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat (2005) 1.07
Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis. Ann Rheum Dis (1975) 1.01
Vascular permeability responses in hypersensitivity. I. The tuberculin reaction. Pathology (1969) 1.01
Vascular permeability responses in hypersensitivity. II. The reaction to 2, 4-dinitrochlorobenzene. Pathology (1969) 0.99
The ethnological significance of the gamma-globulin (Gm) factors in melanesia. Am J Phys Anthropol (1971) 0.99
Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study. J Viral Hepat (2010) 0.96
High frequency of IgG anti-A and -B antibody in old age. Vox Sang (1976) 0.95
Chemiluminescent immunoenzymatic assay for rapid diagnosis of viral infections. J Clin Microbiol (1982) 0.94
Continuous quantitative recording of changes in vascular permeability. Experientia (1967) 0.92
interactions between histamine and bradykinin assessed by continuous recording of increased vascular permeability. J Physiol (1970) 0.92
Enzyme-linked protein A: an enzyme-linked immunosorbent assay reagent for detection of human immunoglobulin G and virus-specific antibody. J Clin Microbiol (1979) 0.91
High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM. Infection (2013) 0.91
Viral immunodiagnosis. Yale J Biol Med (1980) 0.89
Eye patching in unilateral spatial neglect: efficacy of two methods. Arch Phys Med Rehabil (1999) 0.87
Estimating the likelihood of sustained virological response in chronic hepatitis C therapy. J Viral Hepat (2010) 0.86
AFP screening and Down syndrome. Lancet (1985) 0.86
Preparation of P32-phosphanilic acid-bovine serum albumin tracer. Anal Biochem (1968) 0.85
Comparison of chemiluminescence and absorptiometry in enzyme immunoassays for protein quantification. Experientia (1982) 0.84
Distribution of a contact sensitizer, 1-fluoro-2,4-dinitro-benzene, in the the tissues of the guinea-pig. Immunology (1972) 0.83
Vascular permeability responses in hypersensitivity. 3. Reaction to human immunoglobulin. Pathology (1970) 0.83
The validity of the eosin technique as an index of viability. Exp Cell Res (1970) 0.83
Distribution of beta-thalassemia trait and erythrocyte glucose-6-phosphate dehydrogenase deficiency in the Markham River Valley of New Guinea. Am J Phys Anthropol (1967) 0.81
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance. HIV Med (2014) 0.81
Racial difference and biological significance of maternal serum alpha-fetoprotein. Lancet (1986) 0.81
Immunoregulatory abnormalities in children with thrombocytopenic purpura. J Pediatr (1981) 0.81
Reexamination of paternal age effect in Down's syndrome. Hum Genet (1983) 0.79
Continuous recording of dermal exudative reactions. Dermatologica (1970) 0.79
The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals. Eur J Med Res (2010) 0.79
New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age. Am J Obstet Gynecol (1998) 0.78
Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Am J Obstet Gynecol (2000) 0.78
Performance measurement: a good idea in theory. Minn Med (1998) 0.78
Affinity chromatography with specific antibody increases activity and retains antigenicity of ornithine decarboxylase. Prep Biochem (1982) 0.78
ELISA measurement of antibody titer to purified protein derivative and mycobacteria-derived phosphoglycolipids: tool for diagnosing active pulmonary tuberculosis. Isr J Med Sci (1987) 0.77
Measurement of platelet function in dogs using a novel impedance aggregometer. Vet J (2009) 0.77
The prevalence of mycoplasmal complement-fixing antibodies in sarcoidosis. Am Rev Respir Dis (1975) 0.76
Serological evidence for a causative role of non-group A hemolytic streptococci in pharyngitis. Zentralbl Bakteriol Mikrobiol Hyg A (1981) 0.76
Comparison of simian and human cytomegalovirus reactivities in an enzyme-linked immunospecific assay: effect of antigen preparation on cross-reactive antigens. Infect Immun (1982) 0.75
A small electrolytically driven infusion pump. J Appl Physiol (1965) 0.75
A lack of justification for routine screening assays for syphilis in general hospital psychiatric patients. Compr Psychiatry (1987) 0.75
Letter: Alpha-fetoprotein as an indicator of fetal condition. Lancet (1975) 0.75
Maternal serum alpha-fetoprotein in diabetic pregnancy: correlation with blood glucose control. Lancet (1987) 0.75
Will for-profit health care give nonprofits a run for their money? Minn Med (1997) 0.75
How will consumers use report cards in selecting health plans? Manag Care Q (1995) 0.75
Stimulation of lymphocyte transformation by 1-fluoro-2,4-dinitrobenzene. Experientia (1969) 0.75
The wrinkly skin syndrome: a report of a case and review of the literature. Clin Genet (1990) 0.75
Who should own America's healthcare systems? Health Syst Lead (1996) 0.75
Serum hyperglycosylated hCG: a potential screening test for fetal Down syndrome. Prenat Diagn (1999) 0.75
A high frequency of cold agglutinins of anti-IA specificity in a New Guinea highland population. Vox Sang (1970) 0.75
Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome. Am J Obstet Gynecol (1999) 0.75
[Smoking behavior during pregnancy of women with type 1 or gestational diabetes]. Dtsch Med Wochenschr (2007) 0.75
N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART. Eur J Med Res (2007) 0.75
Sodium azide, an efficient inhibitor of protein diazotization. Experientia (1972) 0.75
Special report. Managed care review: market developments in Denver and the Twin Cities. Health Syst Lead (1997) 0.75
The cost of coverage. Minn Med (2000) 0.75
Rise in maternal serum alpha-fetoprotein concentration after chorionic villus sampling and the possibility of isoimmunization. Am J Obstet Gynecol (1986) 0.75
The association of congenital skin disorders with acetylcholinesterase in amniotic fluid. Prenat Diagn (1987) 0.75
Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation. Ultrasound Obstet Gynecol (2000) 0.75
[Pyomyositis]. Harefuah (1982) 0.75
[Typhoid fever after splenectomy]. Harefuah (1988) 0.75
The usefulness of routine screening for salivary secretory component. J Allergy Clin Immunol (1991) 0.75
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection. J Viral Hepat (2014) 0.75
Blood group, erythrocyte acid phosphatase, serum group specific component, haptoglobin and transferrin gene frequencies amongst the Gogodara (Balimo), Kuman (Minj) and Enga (Laiagam) and peoples of New Guinea. Hum Biol Oceania (1973) 0.75
C-reactive protein as early predictor of liver viability after transplantation. Lancet (1984) 0.75
Freedom of choice ... at a price. Minn Med (1997) 0.75
[Severe asthmatic attack induced by artofen]. Harefuah (1987) 0.75
[Legionnaire's disease]. Harefuah (1984) 0.75
Doling out risk. How capitation measures up in Minnesota. Minn Med (1995) 0.75
Pulling for reform. Minn Med (1994) 0.75
Distribution of the group specific (Gc) serum component in the populations of the Markham Valley, New Guinea. Am J Phys Anthropol (1967) 0.75
Endemic autoimmunity: cold auto-agglutinins in Melanesia. Br J Haematol (1968) 0.75
The distribution of haptoglobin and transferrin types in northeast New Guinea. Am J Phys Anthropol (1968) 0.75
The Minnesota experiment. Bus Health (1996) 0.75
Amniotic fluid alpha-fetoprotein concentrations in twin gestations: dependence on placental membrane anatomy. Am J Obstet Gynecol (1988) 0.75
[Hypoglycemia, jaundice and shock complicating relapsing fever]. Harefuah (1984) 0.75
[Cross-reaction of human breast cancers with the envelope glycoprotein gp 52 of the mouse mamma tumorvirus (MMTV)]. Verh Dtsch Ges Pathol (1981) 0.75